Skip to main content
Clinical Trials/IRCT20191013045092N3
IRCT20191013045092N3
Recruiting
Phase 3

Comparison of the therapeutic effect of intralesional injection of botulinum toxin with placebo in patients with androgenetic alopecia receiving finasteride tab

Shiraz University of Medical Sciences0 sites48 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
male androgenetic alopecia.
Sponsor
Shiraz University of Medical Sciences
Enrollment
48
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Being male and older than 18 years 2\. Suffering from androgenic alopecia grade 3 to 5 based on the Norwood Hamilton classification and Not receiving treatment for androgenic alopecia during the last 3 months

Exclusion Criteria

  • 1\. Severe diseases of internal organs, eyes or skin 2\. Diseases of the neuromuscular system 3\. Inflammation, infection or unhealed wounds on the skin around the injection site on the head 4\. Receiving systematic treatment with corticosteroids or other immunosuppressants and immune modulators in the last 3 months 5\. Receiving anticoagulant and antiplatelet drugs 6\. Hair transplantation in the past 7\. Infectious underlying disease, autoimmune, malignancy 8\. Phobia about treatment with botulinum toxin 9\. Reluctance to continue Study participation during treatment and follow\-up

Outcomes

Primary Outcomes

Not specified

Similar Trials